MedPath

Effects of Activity and Education Program on Patients With Chronic Hepatitis C Infection

Not Applicable
Conditions
Hepatitis C Virus Infection, Response to Therapy of
Interventions
Behavioral: Personalized Physical Activity and Psycho-Education (PPAPE) Program
Registration Number
NCT01572233
Lead Sponsor
National Taiwan University Hospital
Brief Summary

This 4-year project will be guided by a biobehavioral model for the study of exercise interventions in two phases with the purposes to :

1. explore the patients' physical activity preferences and develop doable activity lists during treatment period

2. examine the changes of health-related physical fitness component over interferon treatment

3. develop the Personalized Physical Activity and Psych-Education (PPAPE) Program and test its effects on decreasing fatigue, physical and psychological distress, and improving their health-related physical fitness and quality of life in patients with chronic hepatitis C receiving Interferon with Ribavirin Combination Therapy

4. evaluate the outcome of the PPAPE program on increasing adherence to therapy, the sustained virological response (SVR) in 24 weeks after the end of treatment, and the time-consuming for education program during intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Patients with Chronic Hepatitis C Infection Receiving Interferon Therapy
  • Aged above 18
Read More
Exclusion Criteria
  • None
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Patient with HCV InfectionPersonalized Physical Activity and Psycho-Education (PPAPE) ProgramPersonalized Physical Activity and Psycho-Education (PPAPE) Program will be tested on this group.
Primary Outcome Measures
NameTimeMethod
Effects of Activity and Education Program on Patients with Chronic Hepatitis C Infection4-year project

Phase I of this project, the first and second year, the measurement time will be collected on the baseline (before treatment, T0), the 8 weeks (T1), 16 weeks (T2), and 24 weeks (T3) during treatment.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath